Literature DB >> 15050686

Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies.

Yuri Umeda1, Sayuri Taniguchi, Kunimasa Arima, Yue-Shan Piao, Hitoshi Takahashi, Takeshi Iwatsubo, David Mann, Masato Hasegawa.   

Abstract

Abnormalities in tau mRNA splicing cause frontotemporal dementia and parkinsonism linked to chromosome 17, and similar alterations are suggested in sporadic tauopathies such as progressive supranuclear palsy (PSP) or corticobasal degeneration (CBD). We have analyzed the expression of three-repeat (3R) and four-repeat (4R) tau isoforms in brains with familial and sporadic tauopathies. By RT-PCR analysis, decreased levels of 3R tau mRNA were detected not only in severely affected cases with progressive supranuclear palsy or corticobasal degeneration but also in cases with Alzheimer's disease or Pick's disease. Levels of 3R tau transcripts were closely correlated with levels of neurofilament transcripts. By contrast, expressions of glial fibrillary acidic protein and myelin basic protein were similar in all brains. These results suggest that decrease of 3R tau mRNA associated with loss of neuronal element may largely contribute to the increased ratio of 4R/3R tau mRNA in sporadic tauopathies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15050686     DOI: 10.1016/j.neulet.2004.01.060

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Tau as a biomarker of neurodegenerative diseases.

Authors:  Susanna Schraen-Maschke; Nicolas Sergeant; Claire-Marie Dhaenens; Stéphanie Bombois; Vincent Deramecourt; Marie-Laure Caillet-Boudin; Florence Pasquier; Claude-Alain Maurage; Bernard Sablonnière; Eugeen Vanmechelen; Luc Buée
Journal:  Biomark Med       Date:  2008-08       Impact factor: 2.851

2.  RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5' splice site.

Authors:  Amar Kar; Kazuo Fushimi; Xiaohong Zhou; Payal Ray; Chen Shi; Xiaoping Chen; Zhiren Liu; She Chen; Jane Y Wu
Journal:  Mol Cell Biol       Date:  2011-02-22       Impact factor: 4.272

Review 3.  Small-molecule PET Tracers for Imaging Proteinopathies.

Authors:  Chester A Mathis; Brian J Lopresti; Milos D Ikonomovic; William E Klunk
Journal:  Semin Nucl Med       Date:  2017-07-13       Impact factor: 4.446

Review 4.  Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation.

Authors:  Paraskevi Tziortzouda; Ludo Van Den Bosch; Frank Hirth
Journal:  Nat Rev Neurosci       Date:  2021-03-02       Impact factor: 34.870

5.  Hsp70 alters tau function and aggregation in an isoform specific manner.

Authors:  Kellen Voss; Benjamin Combs; Kristina R Patterson; Lester I Binder; T Chris Gamblin
Journal:  Biochemistry       Date:  2012-01-23       Impact factor: 3.162

6.  Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome.

Authors:  Jerzy Wegiel; Wojciech Kaczmarski; Madhabi Barua; Izabela Kuchna; Krzysztof Nowicki; Kuo-Chiang Wang; Jarek Wegiel; Shuang Ma Yang; Janusz Frackowiak; Bozena Mazur-Kolecka; Wayne P Silverman; Barry Reisberg; Isabel Monteiro; Mony de Leon; Thomas Wisniewski; Arthur Dalton; Florence Lai; Yu-Wen Hwang; Tatyana Adayev; Fei Liu; Khalid Iqbal; Inge-Grundke Iqbal; Cheng-Xin Gong
Journal:  J Neuropathol Exp Neurol       Date:  2011-01       Impact factor: 3.685

Review 7.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

8.  A microarray configuration to quantify expression levels and relative abundance of splice variants.

Authors:  Pascale Fehlbaum; Caroline Guihal; Laurent Bracco; Olivier Cochet
Journal:  Nucleic Acids Res       Date:  2005-03-10       Impact factor: 16.971

9.  Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer's disease brain.

Authors:  Ayaho Dan; Muneaki Takahashi; Masami Masuda-Suzukake; Fuyuki Kametani; Takashi Nonaka; Hiromi Kondo; Haruhiko Akiyama; Takao Arai; David M A Mann; Yuko Saito; Hiroyuki Hatsuta; Shigeo Murayama; Masato Hasegawa
Journal:  Acta Neuropathol Commun       Date:  2013-08-21       Impact factor: 7.801

10.  Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau.

Authors:  Sayuri Taniguchi-Watanabe; Tetsuaki Arai; Fuyuki Kametani; Takashi Nonaka; Masami Masuda-Suzukake; Airi Tarutani; Shigeo Murayama; Yuko Saito; Kunimasa Arima; Mari Yoshida; Haruhiko Akiyama; Andrew Robinson; David M A Mann; Takeshi Iwatsubo; Masato Hasegawa
Journal:  Acta Neuropathol       Date:  2015-11-04       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.